{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T03:08:21Z","timestamp":1648868901339},"reference-count":20,"publisher":"Japan Atherosclerosis Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Atheroscler Thromb","JAT"],"published-print":{"date-parts":[[2005]]},"DOI":"10.5551\/jat.12.48","type":"journal-article","created":{"date-parts":[[2011,6,16]],"date-time":"2011-06-16T13:45:32Z","timestamp":1308231932000},"page":"48-52","source":"Crossref","is-referenced-by-count":3,"title":["Risk Evaluation of Coronary Heart Disease and Cerebrovascular Disease by the Japan Atherosclerosis Society Guidelines 2002 Using the Cohort of the Holicos-PAT Study"],"prefix":"10.5551","volume":"12","author":[{"given":"Junji","family":"Koizumi","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, School of Medicine, Kanazawa University, Ishikawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masami","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, School of Medicine, Kanazawa University, Ishikawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Miyamoto","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yamanaka Medical Center, Ishikawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoyu","family":"Takeda","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hokuriku Hospital, Ishikawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takio","family":"Ohka","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ishikawa Prefectural Central Hospital, Ishikawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honin","family":"Kanaya","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ishikawa Prefectural Central Hospital, Ishikawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihide","family":"Uno","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ishikawa Prefectural Central Hospital, Ishikawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kousei","family":"Ueda","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Komatsu Municipal Hospital, Ishikawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadayoshi","family":"Takegoshi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Wajima Municipal Hospital, Ishikawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanobu","family":"Wakasugi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Fukui Prefectural Hospital, Fukui, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Ohta","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Takaoka City Hospital, Toyama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuji","family":"Sumitani","sequence":"additional","affiliation":[{"name":"(Present) Sumitani Clinic, Toyama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomio","family":"Kametani","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Koseiren Takaoka Hospital, Toyama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Shinminato City Hospital, Toyama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Fujita","sequence":"additional","affiliation":[{"name":"(Present) Fujita Clinic, Toyama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Senshyu","family":"Hifumi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hokuriku Central Hospital, Toyama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Origasa","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Toyama Medical and Pharmaceutical University, Toyama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Mabuchi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, School of Medicine, Kanazawa University, Ishikawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","unstructured":"(1) Japan Atherosclerosis Society: Japan atherosclerosis society (JAS) guidelines for diagnosis and treatment of atherosclerotic cardiovascular disease. 2002"},{"key":"2","doi-asserted-by":"crossref","unstructured":"(2) Saito Y: Editorial. J Atheroscler Thromb, 11: 101−103, 2004","DOI":"10.5551\/jat.11.101"},{"key":"3","doi-asserted-by":"crossref","unstructured":"(3) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA, 285: 2486−2497, 2001","DOI":"10.1001\/jama.285.19.2486"},{"key":"4","doi-asserted-by":"crossref","unstructured":"(4) Pyorala K, De Backer G, Graham I, Poole-Wilson P, and Wood D: Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur Heart J, 15: 1300−1331, 1994","DOI":"10.1093\/oxfordjournals.eurheartj.a060388"},{"key":"5","unstructured":"(5) Pyorala K and Wood D: Prevention of coronary heart disease in clinical practice. European recommendations revised and reinforced. Eur Heart J, 19: 1413−1415, 1998"},{"key":"6","unstructured":"(6) Joint British recommendations on prevention of coronary heart disease in clinical practice. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association. Heart, 80 Suppl 2: S1−S29, 1998"},{"key":"7","unstructured":"(7) Ramsay LE, Haq IU, Jackson PR, Yeo WW, Pickin DM, and Payne JN: Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield table. Lancet, 348: 387−388, 1996. Erratum in: Lancet, 348: 1251, 1996"},{"key":"8","unstructured":"(8) Assmann G, Cullen P, and Schulte H: Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation, 105: 310−315, 2002. Erratum in: Circulation, 105: 900, 2002"},{"key":"9","unstructured":"(9) Durrington PN, Prais H, Bhatnagar D, France M, Crowley V, Khan J, and Morgan J: Indications for cholesterol-lowering medication: comparison of risk-assessment methods. Lancet, 353: 278−281, 1999. Erratum in: Lancet, 354: 166, 1999"},{"key":"10","doi-asserted-by":"crossref","unstructured":"(10) Kent DM and Griffith J: The Framingham scores overestimated the risk for coronary heart disease in Japanese, Hispanic, and Native American cohorts. ACP Journal Club, 136: 36, 2002","DOI":"10.1136\/ebm.7.1.31"},{"key":"11","doi-asserted-by":"crossref","unstructured":"(11) D’Agostino RB Sr, Grundy S, Sullivan LM, and Wilson P; CHD Risk Prediction Group: Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA, 286: 180−187, 2001","DOI":"10.1001\/jama.286.2.180"},{"key":"12","unstructured":"(12) Mabuchi H, Kita T, Matsuzaki M, Matsuzawa Y, Nakaya N, Oikawa S, Saito Y, Sasaki J, Shimamoto K, and Itakura H; J-LIT Study Group: Japan Lipid Intervention Trial. Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia and coronary heart disease: secondary prevention cohort study of the Japan Lipid Intervention Trial (J-LIT). Circ J, 66: 1096−1100, 2002"},{"key":"13","doi-asserted-by":"crossref","unstructured":"(13) Matsuzaki M, Kita T, Mabuchi H, Matsuzawa Y, Nakaya N, Oikawa S, Saito Y, Sasaki J, Shimamoto K, and Itakura H; J-LIT Study Group: Japan Lipid Intervention Trial. Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia. Circ J, 66: 1987−1095, 2002","DOI":"10.1253\/circj.66.1087"},{"key":"14","doi-asserted-by":"crossref","unstructured":"(14) Fujishima M, Kiyohara Y, Kato I, Ohmura T, Iwamoto H, Nakayama K, Ohmori S, and Yoshitake T: Diabetes and cardiovascular disease in a prospective population survey in Japan: The Hisayama Study. Diabetes, Suppl 3: S14−S16, 1996","DOI":"10.2337\/diab.45.3.S14"},{"key":"15","unstructured":"(15) Sakata K, Hashimoto T, Ueshima H, and Okayama A; NIPPON DATA 80 Research Group: Absence of an association between serum uric acid and mortality from cardiovascular disease: NIPPON DATA 80, 1980-1994. National Integrated Projects for Prospective Observation of Non-communicable Diseases and its Trend in the Aged. Eur J Epidemiol, 17: 461−468, 2001"},{"key":"16","doi-asserted-by":"crossref","unstructured":"(16) Pravastatin use and risk of coronary events and cerebral infarction in japanese men with moderate hypercholesterolemia: the Kyushu Lipid Intervention Study. J Atheroscler Thromb, 7: 110−121, 2000","DOI":"10.5551\/jat1994.7.110"},{"key":"17","doi-asserted-by":"crossref","unstructured":"(17) Koizumi J, Shimizu M, Miyamoto S, Origasa H, and Mabuchi H: Effect of pravastatin-induced LDL-cholesterol reduction on coronary heart disease and cerebrovascular disease in Japanese: Hokuriku lipid coronary heart disease study-pravastatin atherosclerosis trial (Holicos-PAT). J Atheroscler Thromb, 9: 251−259, 2002","DOI":"10.5551\/jat.9.251"},{"key":"18","doi-asserted-by":"crossref","unstructured":"(18) Broedl UC, Geiss HC, and Parhofer KG: Comparison of current guidelines for primary prevention of coronary heart disease: risk assessment and lipid-lowering therapy. J Gen Intern Med, 18: 190−195, 2003","DOI":"10.1046\/j.1525-1497.2003.20207.x"},{"key":"19","unstructured":"(19) Statistics and Information Department, Minister’s Secretariat, Ministry of health, labour and Welfare: Vital statistics of Japan 2003, http:\/\/www. mhlw.go.jp\/toukei\/saikin\/hw\/jinkou\/suikei03\/index.html"},{"key":"20","doi-asserted-by":"crossref","unstructured":"(20) Sheridan S, Pignone M, and Mulrow C: Framingham-based tools to calculate the global risk of coronary heart disease: a systematic review of tools for clinicians. J Gen Intern Med, 18: 1039−1052, 2003","DOI":"10.1111\/j.1525-1497.2003.30107.x"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/12\/1\/12_1_48\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T20:20:54Z","timestamp":1560284454000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/12\/1\/12_1_48\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.12.48","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005]]}}}